Adherence
Discontinuation rates for weight-reducing (WR) diabetes-specific medications are nearly twice as high as those for weight-inducing (WI) medications, indicating poor persistence with preferred therapies.
If you start a weight-reducing diabetes medication, be prepared for a higher chance of stopping it compared to older weight-gain drugs. This is common, so don't be discouraged. Talk to your doctor about managing side effects, starting with a lower dose, or switching to an oral formulation if injections are the issue. Persistence is key to seeing long-term benefits.
Discontinuation of WR medications was nearly twice that of WI medications.
Why this rating
Large, nationally representative US population study (MEPS, n=7402) over 10 years, observational.
Source
Use and continuity of weight‐modifying medications among adults with diabetes and overweight/obesity: US population study
Rodolfo J. Galindo et al. · Obesity · 2023
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →